NCT07930481
Non-invasive Spinal Stimulation for Gait in Genetic Spasticity
StatusEnrolling by Invitation
PhaseNot applicable
SponsorUniversity of Washington
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Spastic Paraplegia Rating Scale (SPRS)
Timeframe: This assessment will be performed at baseline, and again at weeks 2, 4, 8, 10, 12, and 16.
Secondary (12)
Lower extremity dynamometry
25-foot timed walk test
2-minute walk test
Hmax/Mmax ratio
Mini-Balance Evaluation Systems Test (Mini-BEST)
Show 7 moreShow less
Patient Global Impression of Change (PGIC)
Clinician Global Assessment of Change (CGIC).
Neuropathic Bladder Symptom Score (NBSS)
Neuropathic Bowel Dysfunction Scale (NBDS)
Neuropathic Pain Symptom Inventory (NPSI)
Patient Reported Outcome Measurement Information Systems (PROMIS) Item Bank v1.0 - Pain Interference - Short Form 8a
Modified Ashworth Scale (MAS)
Arms and interventions
Sham StimulationSham comparator
Participants will undergo intensive locomotor training combined with sham stimulation
Active StimulationActive comparator
Participants will undergo active stimulation combined with intensive locomotor training.
Devices: Transcutaneous spinal cord stimulation, Sham transcutaneous spinal cord stimulation
Sites
1 site in 1 country
- John Wallace Hall, Amplify Movement and Performance LaboratorySeattle, Washington, United States